$KYMR
Kymera Therapeutics, Inc.

2022 Q1 Form 10-K Financial Statement

#000095017022001860 Filed on February 24, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021
Revenue $9.622M $15.28M $72.83M
YoY Change -48.55% 19.43% 114.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $10.61M $11.74M $36.35M
YoY Change 79.54% 126.64% 99.37%
% of Gross Profit
Research & Development $35.94M $37.53M $137.0M
YoY Change 38.45% 84.06% 120.62%
% of Gross Profit
Depreciation & Amortization $687.0K $689.0K $2.397M
YoY Change 41.65% 37.8% 35.96%
% of Gross Profit
Operating Expenses $46.56M $49.27M $173.4M
YoY Change 46.07% 92.68% 115.79%
Operating Profit -$36.93M -$100.5M
YoY Change 180.45% 117.11%
Interest Expense $249.0K $94.00K $313.0K
YoY Change 176.67% -6.0% -55.92%
% of Operating Profit
Other Income/Expense, Net $249.0K $313.0K
YoY Change 164.89% -55.98%
Pretax Income -$36.68M -$33.90M -$100.2M
YoY Change 180.46% 167.14% 119.82%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$36.68M -$33.90M -$100.2M
YoY Change 180.57% 167.14% 119.81%
Net Earnings / Revenue -381.25% -221.93% -137.6%
Basic Earnings Per Share -$0.71 -$2.09
Diluted Earnings Per Share -$710.2K -$659.1K -$2.088M
COMMON SHARES
Basic Shares Outstanding 51.70M 51.39M 47.99M
Diluted Shares Outstanding 51.65M 47.99M

Balance Sheet

Concept 2022 Q1 2021 Q4 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $420.8M $442.4M $442.4M
YoY Change 26.18% 49.36% 49.36%
Cash & Equivalents $33.73M $47.98M $47.98M
Short-Term Investments $387.1M $394.4M $394.4M
Other Short-Term Assets $9.307M $8.720M $8.720M
YoY Change 69.22% 85.53% 85.53%
Inventory
Prepaid Expenses
Receivables $1.263M $135.0K $135.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $431.4M $451.3M $451.3M
YoY Change 26.58% 49.26% 49.28%
LONG-TERM ASSETS
Property, Plant & Equipment $11.76M $11.88M $21.31M
YoY Change -42.64% 9.59% 2.93%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $102.5M $125.2M $125.2M
YoY Change 0.86% -22.96% -22.96%
Other Assets $2.022M $2.022M $8.138M
YoY Change 26.38% 6640.0% 408.63%
Total Long-Term Assets $131.7M $154.6M $154.6M
YoY Change 6.36% -16.34% -16.37%
TOTAL ASSETS
Total Short-Term Assets $431.4M $451.3M $451.3M
Total Long-Term Assets $131.7M $154.6M $154.6M
Total Assets $563.1M $605.9M $605.9M
YoY Change 21.19% 24.37% 24.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.567M $4.005M $4.005M
YoY Change -69.07% -8.31% -8.98%
Accrued Expenses $20.78M $22.97M $25.08M
YoY Change 59.82% 122.37% 94.42%
Deferred Revenue $60.85M $61.74M
YoY Change -33.29%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.087M $1.138M $1.138M
YoY Change 81.17% 62.57% 62.57%
Total Short-Term Liabilities $88.34M $92.54M $92.54M
YoY Change -19.79% -16.34% -16.33%
LONG-TERM LIABILITIES
Long-Term Debt $927.0K $1.140M $1.140M
YoY Change 85.4% 90.0% 90.0%
Other Long-Term Liabilities $273.0K $66.00K $52.59M
YoY Change 196.74% -34.0% -42.9%
Total Long-Term Liabilities $273.0K $66.00K $53.73M
YoY Change 196.74% -34.0% -42.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $88.34M $92.54M $92.54M
Total Long-Term Liabilities $273.0K $66.00K $53.73M
Total Liabilities $134.3M $146.3M $146.3M
YoY Change -29.04% -28.05% -28.05%
SHAREHOLDERS EQUITY
Retained Earnings -$265.7M -$229.0M
YoY Change 87.32% 77.83%
Common Stock $697.6M $689.3M
YoY Change 67.25% 66.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $428.7M $459.6M $459.6M
YoY Change
Total Liabilities & Shareholders Equity $563.1M $605.9M $605.9M
YoY Change 21.2% 24.37% 24.36%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021
OPERATING ACTIVITIES
Net Income -$36.68M -$33.90M -$100.2M
YoY Change 180.57% 167.14% 119.81%
Depreciation, Depletion And Amortization $687.0K $689.0K $2.397M
YoY Change 41.65% 37.8% 35.96%
Cash From Operating Activities -$40.30M -$38.35M -$128.9M
YoY Change 76.55% 90.81% -246.31%
INVESTING ACTIVITIES
Capital Expenditures $482.0K -$501.0K $1.597M
YoY Change 193.9% -64.21% -82.44%
Acquisitions
YoY Change
Other Investing Activities $26.35M -$67.52M -$98.24M
YoY Change -40.8% 2496.85% -76.24%
Cash From Investing Activities $25.86M -$68.02M -$99.84M
YoY Change -41.65% 1600.47% -76.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 185.0K 2.054M 250.3M
YoY Change -68.91% 584.67% -13.48%
NET CHANGE
Cash From Operating Activities -40.30M -38.35M -128.9M
Cash From Investing Activities 25.86M -68.02M -99.84M
Cash From Financing Activities 185.0K 2.054M 250.3M
Net Change In Cash -14.25M -104.3M 21.50M
YoY Change -164.48% 338.31% -147.57%
FREE CASH FLOW
Cash From Operating Activities -$40.30M -$38.35M -$128.9M
Capital Expenditures $482.0K -$501.0K $1.597M
Free Cash Flow -$40.78M -$37.85M -$130.5M
YoY Change 77.39% 102.41% -265.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
CY2021 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
CY2021 kymr Reduction Of Right Of Use Asset And Liability Due To Lease Modification
ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification
CY2020 kymr Proceeds From Follow On Offering Net Of Underwriting Discounts And Offering Costs
ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts
CY2019 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
CY2019 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://www.kymeratx.com/20211231#CollaborationRevenuesFromRelatedPartyMember
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
CY2021Q4 kymr Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2020Q4 kymr Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
CY2019 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
CY2021 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
CY2020Q4 kymr Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2019 kymr Premiums And Discounts On Available For Sale Marketable Securities
PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
CY2020 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
CY2019Q4 kymr Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2019 kymr Offering Costs Included In Accounts Payable
OfferingCostsIncludedInAccountsPayable
CY2019 kymr Proceeds From Follow On Offering Net Of Underwriting Discounts And Offering Costs
ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts
CY2019 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2021 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
CY2019Q4 kymr Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2020 kymr Purchases Of Property And Equipment Through Finance And Lease Liabilities
PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 kymr Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q4 kymr Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
CY2020Q4 kymr Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 kymr Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2019 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
CY2019Q4 kymr Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
CY2019 kymr Proceeds From Concurrent Private Placement
ProceedsFromConcurrentPrivatePlacement
CY2020Q4 kymr Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2021 kymr Non Cash Research And Development Expense
NonCashResearchAndDevelopmentExpense
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2020Q4 kymr Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
CY2020 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
CY2020Q4 kymr Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
CY2021 kymr Offering Costs Included In Accounts Payable
OfferingCostsIncludedInAccountsPayable
CY2021Q4 kymr Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2019 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
CY2020 kymr Tenant Improvement Receivable Included In Other Assets
TenantImprovementReceivableIncludedInOtherAssets
CY2019 kymr Increase Decrease In Contract With Customer Asset Related Parties
IncreaseDecreaseInContractWithCustomerAssetRelatedParties
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2021 kymr Tenant Improvement Receivable Included In Other Assets
TenantImprovementReceivableIncludedInOtherAssets
CY2021 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://www.kymeratx.com/20211231#CollaborationRevenuesFromRelatedPartyMember
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 kymr Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2019Q4 kymr Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2019 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://www.kymeratx.com/20211231#CollaborationRevenuesFromRelatedPartyMember
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001815442
CY2019 kymr Reduction Of Right Of Use Asset And Liability Due To Lease Modification
ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-39460
CY2021 dei Entity Registrant Name
EntityRegistrantName
KYMERA THERAPEUTICS, INC.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-2992166
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
200 Arsenal Yards Blvd.
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 230
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Watertown
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02472
CY2021 dei City Area Code
CityAreaCode
857
CY2021 dei Local Phone Number
LocalPhoneNumber
285-5300
CY2021 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2021 dei Trading Symbol
TradingSymbol
KYMR
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021 dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.0001
CY2021Q2 dei Entity Public Float
EntityPublicFloat
1688200000
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
51703544
CY2021 dei Auditor Firm
AuditorFirmId
42
CY2021 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2021 dei Auditor Location
AuditorLocation
Boston, Massachusetts
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47976000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31004000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
394442000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
265198000
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
0
CY2020Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
577000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
135000
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
856000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8720000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4704000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
451273000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
302339000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
125187000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
162531000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11881000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10841000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9426000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9845000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2022000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
30000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
6116000
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1589000
CY2021Q4 us-gaap Assets
Assets
605905000
CY2020Q4 us-gaap Assets
Assets
487175000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4005000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4368000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22971000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10330000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
61739000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
92552000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2461000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2572000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1138000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
689000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
228000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
106000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
92542000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
110617000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
39295000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
77838000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13224000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14128000
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1140000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
604000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
66000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
100000
CY2021Q4 us-gaap Liabilities
Liabilities
146267000
CY2020Q4 us-gaap Liabilities
Liabilities
203287000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51573924
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44592288
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51536181
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44482186
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
5000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
689275000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
412777000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-228982000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128765000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-660000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-128000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
459638000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
283888000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
605905000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
487175000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
72832000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34034000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2934000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
137017000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
62105000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37158000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
959000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-100217000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-45593000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-41246000
CY2021 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-532000
CY2020 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-134000
CY2019 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
6000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-100749000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-45727000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-41240000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36345000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18233000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7981000
CY2021 us-gaap Operating Expenses
OperatingExpenses
173362000
CY2020 us-gaap Operating Expenses
OperatingExpenses
80338000
CY2019 us-gaap Operating Expenses
OperatingExpenses
45139000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-100530000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-46304000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-42205000
CY2021 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
488000
CY2020 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
826000
CY2019 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1005000
CY2021 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
175000
CY2020 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
115000
CY2019 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
46000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
313000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
711000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-100217000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-45593000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-41246000
CY2020 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
9050000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-100217000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-54643000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-41246000
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.09
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.15
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-24.28
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47989023
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17349582
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1698522
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-34436000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
74000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1196000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
6000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-41246000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-74406000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-74406000
CY2020 kymr Exchange Of Convertible Preferred Stock Impact On Equity
ExchangeOfConvertiblePreferredStockImpactOnEquity
-9050000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
162000
CY2020 kymr Stock Issued During Period Value Restricted Stock Vested
StockIssuedDuringPeriodValueRestrictedStockVested
112000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5190000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-134000
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
17003000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
211332000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-45593000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
283888000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
283888000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7633000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
788000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24972000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-532000
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
16207000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-100217000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
459638000
CY2021 us-gaap Profit Loss
ProfitLoss
-100217000
CY2020 us-gaap Profit Loss
ProfitLoss
-45593000
CY2019 us-gaap Profit Loss
ProfitLoss
-41246000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
24972000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
5190000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
1196000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2397000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1763000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
825000
CY2021 kymr Premiums And Discounts On Available For Sale Marketable Securities
PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
5807000
CY2020 kymr Premiums And Discounts On Available For Sale Marketable Securities
PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
1571000
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-18000
CY2020 kymr Non Cash Research And Development Expense
NonCashResearchAndDevelopmentExpense
332000
CY2019 kymr Non Cash Research And Development Expense
NonCashResearchAndDevelopmentExpense
443000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4016000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3816000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
564000
CY2021 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-577000
CY2020 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
577000
CY2021 kymr Increase Decrease In Contract With Customer Asset Related Parties
IncreaseDecreaseInContractWithCustomerAssetRelatedParties
-721000
CY2020 kymr Increase Decrease In Contract With Customer Asset Related Parties
IncreaseDecreaseInContractWithCustomerAssetRelatedParties
856000
CY2019 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-148000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
54000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
990000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
904000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
12599000
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5754000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2248000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-69356000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
117400000
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
52991000
CY2021 kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-419000
CY2020 kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-8444000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7632000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
162000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
74000
CY2021 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
788000
CY2019 kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-1350000
CY2021 kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1015000
CY2020 kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2647000
CY2019 kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-383000
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1992000
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
30000
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
86000
CY2020 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
205000
CY2019 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-7000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-128946000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
88130000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17905000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1597000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9096000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
532000
CY2021 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
456404000
CY2020 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
529382000
CY2019 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
15954000
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
358166000
CY2020 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
115890000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-99835000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-422588000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16486000
CY2021 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
397000
CY2021 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
849000
CY2020 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
554000
CY2019 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
371000
CY2021 kymr Proceeds From Follow On Offering Net Of Underwriting Discounts And Offering Costs
ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts
240760000
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
183146000
CY2021 kymr Proceeds From Concurrent Private Placement
ProceedsFromConcurrentPrivatePlacement
2346000
CY2020 kymr Proceeds From Concurrent Private Placement
ProceedsFromConcurrentPrivatePlacement
13527000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
250280000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
289262000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34911000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
21499000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-45196000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
36330000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32593000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
77789000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
41459000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54092000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32593000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
77789000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
158000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
115000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
46000
CY2021 kymr Purchases Of Property And Equipment Through Finance And Lease Liabilities
PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities
1918000
CY2019 kymr Purchases Of Property And Equipment Through Finance And Lease Liabilities
PurchasesOfPropertyAndEquipmentThroughFinanceAndLeaseLiabilities
1642000
CY2021 kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
42000
CY2020 kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
27000
CY2019 kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
315000
CY2020 kymr Offering Costs Included In Accounts Payable
OfferingCostsIncludedInAccountsPayable
397000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
16522000
CY2019 kymr Tenant Improvement Receivable Included In Other Assets
TenantImprovementReceivableIncludedInOtherAssets
287000
CY2020 kymr Reduction Of Right Of Use Asset And Liability Due To Lease Modification
ReductionOfRightOfUseAssetAndLiabilityDueToLeaseModification
2161000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47976000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31004000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76015000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
6116000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
1589000
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
1774000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54092000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32593000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
77789000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-229000000.0
CY2021Q4 us-gaap Investments And Cash
InvestmentsAndCash
567600000
CY2021 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On August 20, 2020, the Board approved a 1-for-1.5949 reverse stock split of the Company’s issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each of the Company’s outstanding series of preferred stock. All share and per share amounts in the accompanying consolidated financial statements and notes thereto have been retroactively adjusted for all periods presented to give effect to this reverse stock split, including reclassifying an amount equal to the reduction in par value of common stock to additional paid-in capital.
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1.5949
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingencies at the date of the financial statements and the reported amounts of expenses during the reporting period. Management’s estimates and judgments are derived and continually evaluated based on available information, historical experience and various other assumptions that are believed to be reasonable under the circumstances. Because the use of estimates is inherent in the financial reporting process, actual results could differ from those estimates. In recording transactions and balances resulting from business operations, management makes estimates based on the best information available at the time the estimate is made. Significant estimates relied upon in preparing these financial statements include revenue recognized under our collaboration agreement with Sanofi and Vertex, accrual for research and development expenses, equity-based compensation expense, and the valuation of equity. As better information becomes available or actual amounts are determinable, the recorded estimates are revised. Consequently, operating results can be affected by revisions to prior estimates.</span></p>
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P1Y
CY2021 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2020 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2019 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2021Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0
CY2020Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
400000
CY2021Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
520286000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
658000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
519629000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
427863000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
134000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
427729000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
113
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
515400000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
65
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
392200000
CY2021 kymr Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
79
CY2021Q4 kymr Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months
FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
394400000
CY2021 kymr Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
37
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
125200000
CY2020 kymr Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
48
CY2020Q4 kymr Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months
FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
295600000
CY2020 kymr Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
25
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
162500000
CY2020 us-gaap Availableforsale Securities Sold At Par
AvailableforsaleSecuritiesSoldAtPar
1
CY2021 kymr Debt Securities Available For Sale Decline In Market Value For Unrealized Loss Position Number Of Securities
DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities
113
CY2020Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
1433000
CY2021 kymr Contract With Customer Asset Net Additions
ContractWithCustomerAssetNetAdditions
7669000
CY2021 kymr Contract With Customer Asset Net Deductions
ContractWithCustomerAssetNetDeductions
-8967000
CY2021Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
135000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
170390000
CY2021 kymr Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
3475000
CY2021 kymr Contract With Customer Liability Deductions
ContractWithCustomerLiabilityDeductions
-72831000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
101034000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15797000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12988000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3916000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2147000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11881000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10841000
CY2021 us-gaap Depreciation
Depreciation
2400000
CY2020 us-gaap Depreciation
Depreciation
1800000
CY2019 us-gaap Depreciation
Depreciation
800000
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
900000
CY2020 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
700000
CY2019 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
400000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
2095000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
2719000
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
906000
CY2020 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
716000
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
158000
CY2020 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
121000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
1015000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
621000
CY2021 us-gaap Lease Cost
LeaseCost
4174000
CY2020 us-gaap Lease Cost
LeaseCost
4177000
CY2021 kymr Operating Lease Payments Proceeds
OperatingLeasePaymentsProceeds
2691000
CY2020 kymr Operating Lease Payments Proceeds
OperatingLeasePaymentsProceeds
-3024000
CY2021 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
933000
CY2020 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
587000
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
158000
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
121000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y3M18D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y3M18D
CY2021Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M24D
CY2020Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M18D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.105
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.105
CY2021Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.088
CY2020Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.080
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2581000
CY2021Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
1183000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2659000
CY2021Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
968000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2732000
CY2021Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
345000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2814000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2898000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
10027000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
23711000
CY2021Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
2496000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8026000
CY2021Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
218000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
15685000
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
2278000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10330000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1585000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
352000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22971000
CY2021Q4 kymr Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
15169000
CY2020Q4 kymr Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
5821000
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
6033000
CY2020Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2918000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1417000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M13D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M2D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y5M26D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.66
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.70
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.71
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.005
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0183
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24972000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5190000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1196000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.106
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0580
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.070
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.096
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.009
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.006
CY2021 kymr Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.000
CY2020 kymr Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.0000
CY2019 kymr Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.077
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0360
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.020
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.051
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.007
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.438
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.288
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.294
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
25957000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
15621000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
6651000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
3866000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
14611000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
3757000
CY2021Q4 kymr Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
4285000
CY2020Q4 kymr Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
4563000
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
27130000
CY2020Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
10313000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
5156000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
1589000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
83790000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
39709000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
77990000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
34075000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
5800000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
5634000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
1941000
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
1506000
CY2021Q4 kymr Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
3859000
CY2020Q4 kymr Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
4128000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
78000000.0
CY2020Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
34100000
CY2021 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
43900000
CY2021 kymr Federal Net Operating Loss Carryovers Not Subject To Expiration
FederalNetOperatingLossCarryoversNotSubjectToExpiration
113800000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2020 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-100217000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-45593000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-41246000
CY2020 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
9050000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-100217000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-54643000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-41246000
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47989023
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17349582
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1698522
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.09
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.15
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-24.28
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6276927
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1691028
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25503512

Files In Submission

Name View Source Status
0000950170-22-001860-index-headers.html Edgar Link pending
0000950170-22-001860-index.html Edgar Link pending
0000950170-22-001860.txt Edgar Link pending
0000950170-22-001860-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img12902699_0.jpg Edgar Link pending
img12902699_1.jpg Edgar Link pending
img12902699_10.jpg Edgar Link pending
img12902699_11.jpg Edgar Link pending
img12902699_12.jpg Edgar Link pending
img12902699_13.jpg Edgar Link pending
img12902699_2.jpg Edgar Link pending
img12902699_3.jpg Edgar Link pending
img12902699_4.jpg Edgar Link pending
img12902699_5.jpg Edgar Link pending
img12902699_6.jpg Edgar Link pending
img12902699_7.jpg Edgar Link pending
img12902699_8.jpg Edgar Link pending
img12902699_9.jpg Edgar Link pending
img253269942_0.jpg Edgar Link pending
img253269942_1.jpg Edgar Link pending
img253269942_10.jpg Edgar Link pending
img253269942_11.jpg Edgar Link pending
img253269942_12.jpg Edgar Link pending
img253269942_13.jpg Edgar Link pending
img253269942_14.jpg Edgar Link pending
img253269942_15.jpg Edgar Link pending
img253269942_16.jpg Edgar Link pending
img253269942_17.jpg Edgar Link pending
img253269942_18.jpg Edgar Link pending
img253269942_19.jpg Edgar Link pending
img253269942_2.jpg Edgar Link pending
img253269942_20.jpg Edgar Link pending
img253269942_21.jpg Edgar Link pending
img253269942_22.jpg Edgar Link pending
img253269942_23.jpg Edgar Link pending
img253269942_24.jpg Edgar Link pending
img253269942_25.jpg Edgar Link pending
img253269942_26.jpg Edgar Link pending
img253269942_27.jpg Edgar Link pending
img253269942_28.jpg Edgar Link pending
img253269942_29.jpg Edgar Link pending
img253269942_3.jpg Edgar Link pending
img253269942_30.jpg Edgar Link pending
img253269942_31.jpg Edgar Link pending
img253269942_32.jpg Edgar Link pending
img253269942_33.jpg Edgar Link pending
img253269942_34.jpg Edgar Link pending
img253269942_35.jpg Edgar Link pending
img253269942_36.jpg Edgar Link pending
img253269942_37.jpg Edgar Link pending
img253269942_38.jpg Edgar Link pending
img253269942_39.jpg Edgar Link pending
img253269942_4.jpg Edgar Link pending
img253269942_40.jpg Edgar Link pending
img253269942_41.jpg Edgar Link pending
img253269942_42.jpg Edgar Link pending
img253269942_43.jpg Edgar Link pending
img253269942_44.jpg Edgar Link pending
img253269942_45.jpg Edgar Link pending
img253269942_46.jpg Edgar Link pending
img253269942_47.jpg Edgar Link pending
img253269942_5.jpg Edgar Link pending
img253269942_6.jpg Edgar Link pending
img253269942_7.jpg Edgar Link pending
img253269942_8.jpg Edgar Link pending
img253269942_9.jpg Edgar Link pending
kymr-20211231.htm Edgar Link pending
kymr-20211231.xsd Edgar Link pending
kymr-20211231_cal.xml Edgar Link unprocessable
kymr-20211231_def.xml Edgar Link unprocessable
kymr-20211231_htm.xml Edgar Link completed
kymr-20211231_lab.xml Edgar Link unprocessable
kymr-20211231_pre.xml Edgar Link unprocessable
kymr-ex10_15.htm Edgar Link pending
kymr-ex10_16.htm Edgar Link pending
kymr-ex10_3.htm Edgar Link pending
kymr-ex21_1.htm Edgar Link pending
kymr-ex23_1.htm Edgar Link pending
kymr-ex31_1.htm Edgar Link pending
kymr-ex31_2.htm Edgar Link pending
kymr-ex32_1.htm Edgar Link pending
kymr-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending